Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric J Sherman

Showing results (21-30 of 113) with videos related to

Pageof 12
Sort By:
The Lancet. Oncology|July 28, 2016
Vemurafenib in patients with BRAF(V600E)-positive metastatic or unresectable papillary thyroid cancer refractory to radioactive iodine: a non-randomised, multicentre, open-label, phase 2 trialMarcia S Brose, Maria E Cabanillas, Ezra E W Cohen, et al.
Head & Neck|November 22, 2012
Sharing a diagnosis of HPV-related head and neck cancer: the emotions, the confusion, and what patients want to knowShrujal S Baxi, Andrew G Shuman, Geoffrey W Corner, et al.
Oral Oncology|July 22, 2014
The relative prognostic utility of standardized uptake value, gross tumor volume, and metabolic tumor volume in oropharyngeal cancer patients treated with platinum based concurrent chemoradiation with a pre-treatment [(18)F] fluorodeoxyglucose positron emission tomography scanPaul B Romesser, Remy Lim, Daniel E Spratt, et al.
Head & Neck|November 14, 2018
Long-term quality of life in older patients with HPV-related oropharyngeal cancerShrujal S Baxi, Grace Cullen, Han Xiao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 31, 2004
Using patients as their own controls for cost evaluation of phase I clinical trialsEric J Sherman, David M Rubin, Ennapadam Venkatraman, et al.
JAMA Network Open|September 30, 2024
Tumor Hypoxia on 18F-fluoromisonidazole Positron Emission Tomography and Distant Metastasis From Head and Neck Squamous Cell CarcinomaChengcheng Gui, Rick Wray, Heiko Schöder, et al.
Oral Oncology|August 19, 2015
Palliative head and neck radiotherapy with the RTOG 8502 regimen for incurable primary or metastatic cancersBenjamin H Lok, Ginger Jiang, Stanley Gutiontov, et al.
Journal of the American Medical Informatics Association : JAMIA|July 28, 2025
Real-world evaluation of user engagement with an artificial intelligence-powered clinical trial application in oncologyTony K W Hung, Jun J Mao, Alan L Ho, et al.
Cancer|June 19, 2012
Percutaneous endoscopic gastrostomy in oropharyngeal cancer patients treated with intensity-modulated radiotherapy with concurrent chemotherapyPaul B Romesser, Jonathan C Romanyshyn, Karen D Schupak, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 13, 2016
Proton beam radiation therapy results in significantly reduced toxicity compared with intensity-modulated radiation therapy for head and neck tumors that require ipsilateral radiationPaul B Romesser, Oren Cahlon, Eli Scher, et al.
Pageof 12

Showing results (21-30 of 113) with videos related to

Sort By:
Pageof 12
The Lancet. Oncology|July 28, 2016
Vemurafenib in patients with BRAF(V600E)-positive metastatic or unresectable papillary thyroid cancer refractory to radioactive iodine: a non-randomised, multicentre, open-label, phase 2 trialMarcia S Brose, Maria E Cabanillas, Ezra E W Cohen, et al.
Head & Neck|November 22, 2012
Sharing a diagnosis of HPV-related head and neck cancer: the emotions, the confusion, and what patients want to knowShrujal S Baxi, Andrew G Shuman, Geoffrey W Corner, et al.
Oral Oncology|July 22, 2014
The relative prognostic utility of standardized uptake value, gross tumor volume, and metabolic tumor volume in oropharyngeal cancer patients treated with platinum based concurrent chemoradiation with a pre-treatment [(18)F] fluorodeoxyglucose positron emission tomography scanPaul B Romesser, Remy Lim, Daniel E Spratt, et al.
Head & Neck|November 14, 2018
Long-term quality of life in older patients with HPV-related oropharyngeal cancerShrujal S Baxi, Grace Cullen, Han Xiao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 31, 2004
Using patients as their own controls for cost evaluation of phase I clinical trialsEric J Sherman, David M Rubin, Ennapadam Venkatraman, et al.
JAMA Network Open|September 30, 2024
Tumor Hypoxia on 18F-fluoromisonidazole Positron Emission Tomography and Distant Metastasis From Head and Neck Squamous Cell CarcinomaChengcheng Gui, Rick Wray, Heiko Schöder, et al.
Oral Oncology|August 19, 2015
Palliative head and neck radiotherapy with the RTOG 8502 regimen for incurable primary or metastatic cancersBenjamin H Lok, Ginger Jiang, Stanley Gutiontov, et al.
Journal of the American Medical Informatics Association : JAMIA|July 28, 2025
Real-world evaluation of user engagement with an artificial intelligence-powered clinical trial application in oncologyTony K W Hung, Jun J Mao, Alan L Ho, et al.
Cancer|June 19, 2012
Percutaneous endoscopic gastrostomy in oropharyngeal cancer patients treated with intensity-modulated radiotherapy with concurrent chemotherapyPaul B Romesser, Jonathan C Romanyshyn, Karen D Schupak, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 13, 2016
Proton beam radiation therapy results in significantly reduced toxicity compared with intensity-modulated radiation therapy for head and neck tumors that require ipsilateral radiationPaul B Romesser, Oren Cahlon, Eli Scher, et al.
Pageof 12